Divis Laboratories Ltd reported 9.1B in Trade Creditors for its fiscal quarter ending in March of 2025.


Trade Creditors Change Date
Alaunos Therapeutics USD 516K 58K Dec/2024
Aurobindo Pharma INR 41.89B 2.44B Mar/2025
Avita Medical 6.29M 2.13M Dec/2024
Dianthus Therapeutics USD 5.4M 825K Jun/2025
Divis Laboratories Ltd 9.1B 550M Mar/2025
Ionis Pharmaceuticals USD 22.8M 5.34M Jun/2025
IQVIA Holdings 3.4B 160M Jun/2025
Lupin INR 29.58B 36M Mar/2025
Moderna USD 175M 51M Jun/2025
Organon & Co USD 1.07B 61M Jun/2025
Revvity USD 178.15M 65K Jun/2025
Tectonic Therapeutic USD 2.8M 1.82M Jun/2025
Tilray USD 99.08M 2.79M Nov/2024
Viatris USD 1.32B 198.2M Jun/2025
Xeris Pharmaceuticals USD 9.46M 7.17M Jun/2025